BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: González LF, Bevilacqua LE, Naves R. Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases. Pharmaceutics 2021;13:2055. [PMID: 34959337 DOI: 10.3390/pharmaceutics13122055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jurcau A, Jurcau CM. Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 2023;18:1472-7. [PMID: 36571344 DOI: 10.4103/1673-5374.360289] [Reference Citation Analysis]
2 Hanaford A, Johnson SC. The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence. Orphanet J Rare Dis 2022;17:335. [PMID: 36056365 DOI: 10.1186/s13023-022-02495-3] [Reference Citation Analysis]
3 Atayik MC, Çakatay U. Mitochondria-targeted senotherapeutic interventions. Biogerontology 2022. [PMID: 35781579 DOI: 10.1007/s10522-022-09973-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Rakotoarisoa M, Angelov B, Drechsler M, Nicolas V, Bizien T, Gorshkova YE, Deng Y, Angelova A. Liquid crystalline lipid nanoparticles for combined delivery of curcumin, fish oil and BDNF: In vitro neuroprotective potential in a cellular model of tunicamycin-induced endoplasmic reticulum stress. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]